SARS-CoV-2 vulnerability and COVID-19 severity association with ABO blood group
| Autor: | Shikun ZHANG, Hailong ZHUO, Yingxia TAN, Feng GONG |
|---|---|
| Jazyk: | čínština |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Zhongguo shuxue zazhi, Vol 35, Iss 1, Pp 114-118 (2022) |
| Druh dokumentu: | article |
| ISSN: | 1004-549X 1004-549x 57659427 |
| DOI: | 10.13303/j.cjbt.issn.1004-549x.2022.01.033&lang=en |
| Popis: | Studies have shown that ABO blood group is related to the susceptibility and disease progression of SARS-CoV-2 infection, and most studies indicated that group O individuals were less likely to get infected while group A conferred a higher susceptibility to infection and propensity to severe disease. ABO blood group antigens are oligosaccharides expressed on red cells and other tissues. People with different ABO blood type have different susceptibility to a variety of pathogens, including SARS-CoV-2. There are several hypotheses to explain the differences in SARS-CoV-2 infection between ABO blood group individuals. Firstly, anti-A and/or anti-B antibodies could bind to corresponding antigens on the viral envelope and contribute to viral neutralization, thereby preventing target cell from being infected. The SARS-CoV-2 virus and SARS-CoV spike (S) proteins may be bound by anti-A isoagglutinin, which may block interactions between virus and angiotensin-converting-enzyme-2-receptor, thereby preventing entering into lung epithelial cells. Secondly, the receptor binding domain (RBD) of S protein domain can bind to antigen A expressed in respiratory epithelium and promote its infection to respiratory epithelial cells. In conclusion, most studies indicated that group O may be associated with a lower risk of SARS-CoV-2 infection while group A with a higher risk along with severe disease, and the related mechanism needs to be further studied. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|